For Bill Hait, the or so compelling perception is that which holds the greatest promise for developing medicines that address high unmet needs. A network that allows you to have insights into what is going on in the military man of science is essential, says Hait, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. It takes an understanding of both the medical exam need and the most compelling science to get important innovations to patients quickly.
One example is ZYTIGA® (abiraterone acetate), an oral, once-daily medication for use in conclave with prednisone for the treatment of men with metastatic castration-resistant prostate genus Cancer (CRPC) who have received prior chemotherapy containing docetaxel. The U.S. Food and Drug institution granted marting approval for ZYTIGA® in April 2011 after an expedited six-month review. An intensify regulatory review process granted by the European Medicines Agency led to marketing authorization by the European Commission in September 2011.
Prostate cancer is the atomic number 16 most oftentimes diagnosed cancer among men and the fifth most earthy cancer overall.
How this transformative prostate cancer treatment came to market exemplifies a fundamental shift in the approach to question and development that is being applied across Janssen Research & Development.
TRANSFORMING prostatic CANCER TREATMENT
Globally, prostate cancer is the second most frequently diagnosed cancer in men and the fifth most common cancer overall. According to estimates by the National Cancer Institute, to a greater extent than 240,000 new cases of prostate cancer were diagnosed in the U.S. in 2011, maculation nearly 34,000 men died from the disease.
Androgen hormones, such as testosterone, argon known to fuel prostate cancer tumors, and despite chemical or surgical reduction of hormones, some cancers continue to trust on them. Before the approval of ZYTIGA®, treatment options to extend support for men with this kind of metastatic...If you want to get a just essay, order it on our website: Ordercustompaper.com
If you want to get a full essay, wisit our page: write my paper
No comments:
Post a Comment